HutchMED (China) LIMITED Investing Cash Flow
HutchMED (China) LIMITED (HCM) reported Investing Cash Flow of -$29.41 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-05
- HutchMED (China) LIMITED net cash provided by (used in) investing activities for the quarter ending 2019-12-31 was $14.22M.
- HutchMED (China) LIMITED net cash provided by (used in) investing activities for the quarter ending 2019-09-30 was $47.67M, a 10.29% increase year-over-year.
- HutchMED (China) LIMITED net cash provided by (used in) investing activities for the quarter ending 2019-06-30 was $23.76M.
- HutchMED (China) LIMITED net cash provided by (used in) investing activities for the quarter ending 2019-03-31 was $33.38M, a 20.47% increase year-over-year.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$29.41M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $17.59M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | -$96.06M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | -$5.43M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | -$291.14M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | -$315.96M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $296.59M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $259.71M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | -$306.32M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | -$155.89M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | -$125.44M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | -$139.12M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $14.22M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $61.89M derived: sum of 2 quarters · filed 2022-03-03 | $85.65M derived: sum of 3 quarters · filed 2022-03-03 | $119.03M 20-F · filed 2022-03-03 |
| 2019-09-30 | $47.67M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $71.43M derived: sum of 2 quarters · filed 2020-07-30 | $104.81M 6-K · filed 2020-01-21 | $89.55M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $23.76M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $57.14M 6-K · filed 2020-07-30 | $41.88M derived: sum of 3 quarters · filed 2021-03-04 | $85.10M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $33.38M 6-K · filed 2019-06-06 | $18.12M derived: sum of 2 quarters · filed 2021-03-04 | $61.34M derived: sum of 3 quarters · filed 2021-03-04 | $49.42M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$15.26M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $27.96M derived: sum of 2 quarters · filed 2021-03-04 | $16.04M derived: sum of 3 quarters · filed 2021-03-04 | $43.75M 20-F · filed 2021-03-04 |
| 2018-09-30 | $43.22M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $31.30M derived: sum of 2 quarters · filed 2020-01-21 | $59.01M 6-K · filed 2020-01-21 | |
| 2018-06-30 | -$11.92M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $15.79M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $27.71M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | -$260.78M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $14.22M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | -$33.60M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | -$53.16M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $8.86M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | -$15.22M 20-F · filed 2017-03-13 |